Latanoprost Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.
Conditions:   Glaucoma, Open-Angle;   Ocular Hypertension Intervention:   Drug: tafluprost/timolol Sponsor:   Fondazione G.B. Bietti, IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2022 Category: Research Source Type: clinical trials

Rocklatan ® Evaluation
Condition:   Glaucoma Intervention:   Drug: Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005% Sponsor:   Aerie Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2022 Category: Research Source Type: clinical trials